CL
ASND icon

Choreo LLC’s Ascendis Pharma A/S ASND Stock Holding History

Choreo LLC’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Hold
1,421
– – ﹤0.01% 1173
2026
Q1 		$325K Buy
1,421
+3
+0.2% +$673 ﹤0.01% 1198
2025
Q4 		$297K Sell
1,418
-6
-0.4% -$1.24K ﹤0.01% 1223
2025
Q3 		$283K Buy
1,424
+46
+3% +$8.58K ﹤0.01% 1261
2025
Q2 		$238K Buy
+1,378
New +$224K ﹤0.01% 1312

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Choreo LLC's ASND Position: Q2 2026 in Review

Choreo LLC held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 1,421 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

Choreo LLC first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Choreo LLC held 1,421 shares of Ascendis Pharma A/S worth $379K as of Q2 2026.
  • Choreo LLC left its Ascendis Pharma A/S share count unchanged in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1173 holding.
  • Choreo LLC first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.